Principal ScientistAmgen Inc.Thousand Oaks, California, United States
Addressing the Challenge of Drug-Induced Kidney Injury (DIKI) within Preclinical Drug Development (S01)
Monday, November 18, 20249:00 AM - 12:00 PM CT
Introduction (S01-1)
Monday, November 18, 20249:00 AM - 9:15 AM CT